Skip to content

Prediction of Maternal Arterial Hypotension After Spinal Anesthesia by Passive Leg Raise Test.

Assessment of the Value of Passive Leg Raising (PLR) in Predicting the Onset of Maternal Arterial Hypotension and Norepinephrine Requirements After Spinal Anesthesia for Scheduled Cesarean Section.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05133271
Acronym
EDLIDL
Enrollment
64
Registered
2021-11-24
Start date
2021-02-03
Completion date
2024-08-03
Last updated
2025-09-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean, Spinal Anesthesia

Keywords

Passive leg raise test (PLR), Cesarean section, Spinal anesthesia, Maternal arterial hypotension, Phenylephrine requirements, Norepinephrine requirements

Brief summary

Spinal anesthesia for cesarean section is associated with a high incidence of low blood pressure. However, the pathophysiology of this arterial hypotension is not unequivocal and could involve, in addition to drug vasoplegia, a mechanical cause linked to lower caval compression or even true or relative hypovolemia. Passive leg raise test has been proposed in an attempt to identify parturients who are more likely to develop low blood pressure after spinal anesthesia. Nevertheless, the data available on this volume expansion test to predict hemodynamic variations after performing spinal anesthesia are still limited and few objective criteria have been described to predict this arterial hypotension. The objective of the research is to study the hypothesis according to which the presence of hypovolaemia (true or relative) objectified by a positive passive leg raise test would cause hypotension more frequent and more marked in intensity.

Detailed description

Spinal anesthesia for cesarean section is associated with a high incidence of low blood pressure. However, the pathophysiology of this arterial hypotension is not unequivocal and could involve, in addition to drug vasoplegia, a mechanical cause linked to lower caval compression or even true or relative hypovolemia. Passive leg raise test has been proposed in an attempt to identify parturients who are more likely to develop low blood pressure after spinal anesthesia. Nevertheless, the data available on this volume expansion test to predict hemodynamic variations after performing spinal anesthesia are still limited and few objective criteria have been described to predict this arterial hypotension. The objective of the research is to study the hypothesis according to which the presence of hypovolaemia (true or relative) objectified by a positive passive leg raise test would cause hypotension more frequent and more marked in intensity. Patients will have a clinical hemodynamic and echocardiographic evaluation, before performing the spinal anesthesia, before and after the passive leg raise test. Then, the patients will benefit from a clinical hemodynamic evaluation during the preparation of the parturient in the operating room and finally after the completion of the spinal anesthesia and until the clamping of the umbilical cord.

Interventions

OTHERClinical hemodynamic and echocardiographic evaluation

Clinical hemodynamic and echocardiographic evaluation in two stages T1 and T2, before performing the spinal anesthesia, carried out by a doctor different from the doctor in charge of the parturient in the operating room to ensure the blind hemodynamic results before the spinal anesthesia, in particular those of the passive leg raise test (PLR) : 1. T1: clinico-echographic evaluation in dorsal decubitus position (45 °) with cushion under the right buttock. 2. T2: clinico-ultrasound evaluation after performing the PLR. Then, clinical hemodynamic evaluation during two periods T3 and T4: 3. T3: conditioning time of the parturient in the operating room during which clinical hemodynamic monitoring is set up and the basic values of arterial pressures (systolic, diastolic and mean) and heart rate are defined. 4. T4: period after performing spinal anesthesia until clamping of the umbilical cord.

Sponsors

URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult women admitted to Necker Enfants Malades hospital for scheduled cesarean section under spinal anesthesia * Written informed consent

Exclusion criteria

* No health insurance * Urgent cesarean * Failure of spinal anesthesia * Free and informed consent impossible to obtain (especially due to a language barrier) * Severe cardiovascular or neurovascular comorbidities * Contraindication to the PLR (intracranial hypertension, fractures of the pelvis and / or lower limbs, ...) * Background of preeclampsia or eclampsia * Severe fetal pathology

Design outcomes

Primary

MeasureTime frameDescription
Maternal arterial hypotensionDay 0Maternal arterial hypotension following spinal anesthesia. Maternal hypotension is defined as a drop in systolic blood pressure (SBP)\> 20% of baseline.
Positivity of passive leg raise testDay 0A positive passive leg raise test is defined as an increase in the Subaortic Flow Velocity Time Integral of 10% or more. The increase in cardiac output is measured by a cardiac ultrasound.
Positive passive leg raise test performanceDay 0Performance of a positive passive leg raise test in predicting the onset of maternal arterial hypotension after spinal anesthesia. Significant performance will be defined by sensitivity and specificity \> 90%.

Secondary

MeasureTime frameDescription
Occurrence of disturbances of consciousnessDay 0Occurrence of consciousness alteration assessed by the Glasgow Coma Scale (from Teasdale G & Jennett B. Lancet 1974). Three aspects of behavior are measured independently: motor response, verbal response and eye opening. Each component has a number of grades starting with the most severe. The best ocular response has 4 grades; the best verbal response has 5 grades; the best motor response has 6 grades. Rating: the score of each component as well as the sum of the components are considered. The total score is out of 15 points; lower scores indicating more severe impairment. The lowest possible score is 3, indicating deep coma or death, and the highest possible score is 15, indicating a fully awake individual.
Occurrence of sedation and agitationDay 0Occurrence of sedation and agitation during the c-section assessed by the Richmond Agitation-Sedation scale (RASS). This score is based on the observation of the patient It has 10 stages ranging from +4 (combative patient) to -5 (patient who cannot be woken up).
Assessment of fetal well-beingDay 0Evaluation of fetal well-being by fetal heartbeat, by the Apgar score at 1, 3 and 5 minutes of life, and study of the pH in the umbilical cord, a pH value \<7.2 defines fetal distress.
Quality of ultrasound imagesDay 0Assessment of obtaining views (parasternal long-axis view, parasternal short-axis view, apical 4-chamber view, subcostal). Interpretability of the measurements obtained.
Relative or absolute hypovolemiaDay 0Describe the echocardiographic parameters reflecting the different physiopathological mechanisms at the origin of arterial hypotension secondary to spinal anesthesia of the parturient at the end of pregnancy. To note the parameters suggestive of relative or absolute hypovolaemia: inferior vena cava diameter \< 8 mm; kissing sign of the left ventricle, defined as à end-systolic collapse of the left ventricle; E/A ratio \< 1.
Total dose of norepinephrineDay 0Total dose of norepinephrine received during the procedure from the beginning of the spinal anesthesia injection up to umbilical cord clamping measured in micrograms.
Left ventricle systolic and diastolic dysfunctionDay 0Describe the echocardiographic parameters reflecting the different physiopathological mechanisms at the origin of arterial hypotension secondary to spinal anesthesia of the parturient at the end of pregnancy. Left ventricle systolic function: left ventricle ejection fraction (LVEF) - apical-4-chamber view - defined as LVEF = (EDLVA-ESLVA)/EDLVA Left ventricle shortening fraction (LVSF) - parasternal short-axis view - defined as LVSF = (EDLVA-ESLVA)/EDLVA MAPSE (mitral annular plane systolic excursion Left ventricle diastolic function: Mitral flow profile: E wave / A wave ratio Left atrium area (cm²)
Pericardial effusionDay 0Describe the echocardiographic parameters reflecting the different physiopathological mechanisms at the origin of arterial hypotension secondary to spinal anesthesia of the parturient at the end of pregnancy. Measurement of the size (in mm) of the pericardial effusion (left and right ventricles lateral walls).
Maternal comfort during the passive leg raisingDay 0Assessment of the maternal comfort during the passive leg raising test with a numerical scale (from 0: maximal discomfort to 10: maximal comfort).
Heart rateDay 0Association of increased up heart rate and total dose of neosynephrine at the end of the c-section.
Right ventricle systolic or diastolic dysfunctionDay 0Describe the echocardiographic parameters reflecting the different physiopathological mechanisms at the origin of arterial hypotension secondary to spinal anesthesia of the parturient at the end of pregnancy. Right ventricle systolic function: measurement of the TAPSE (tricuspid annular plane systolic excursion; presence of a paradoxical septal motion (yes/no). Right ventricle diastolic function: presence of right ventricle dilation defined as end-diastolic right ventricle area (EDRVA) / end-diastolic left ventricle area (EDLVA) \> 0.6; severe dilatation is defined as a ratio \> 1.
Onset of severe arterial hypotensionDay 0Onset of severe arterial hypotension defined as a drop in systolic blood pressure greater than 30% of baseline.
Onset of nausea and vomitingDay 0Onset of nausea and vomiting from the spinal anesthesia injection up to the end of the c-section.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026